Glenmark Pharmaceuticals Inc., USA recalls Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured
Recalled August 30, 2023 · FDA recall D-1095-2023 · Glenmark Pharmaceuticals Inc., USA
Hazard
Subpotent: Out of Specification for Assay Test at the 3-month time point. · FDA Class III
Units
1,200 bottles
Sold at
nationwide in the U.S.
Description
Subpotent: Out of Specification for Assay Test at the 3-month time point.
Product
Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale -Bardez, Goa 403513, India, Manufactured for Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-295-01
Manufacturer(s)
Glenmark Pharmaceuticals Inc., USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →